Skip to main content
. 2020 Mar 18;8(1):e000980. doi: 10.1136/bmjdrc-2019-000980

Figure 2.

Figure 2

(A) Changes in mean insulin dose for patients ever on insulin during the study period. *P<0.001 when compared with visit 1. (B) Changes in in medication dosing for visit 1 to visit 4 for patients ever on medication; n represents the number of participants ever on the medication. DPP-4, dipeptidyl peptidase-4; GLP-1, glucagon-like peptide-1; LCHF, low carbohydrate, high fat; SGLT-2, sodium-glucose transporter-2.